News

13 June 2014

Dimitrios Pentafragas, Founder and Chairman of ELPEN Pharmaceutical Co. Inc. is awarded for his substantial contribution to pharmaceutical research in Greece

An important and moving awards ceremony took place at the Athens Academy Research Center, where the Founder and Chairman of ELPEN Pharmaceutical Co. Inc. was awarded by the Greek Association of Pharmacology and Clinical Pharmacology. The award honored Mr. D. Pentafragas's substantial contribution and long-standing commitment to clinical research aswell as his pioneering support and encouragement to researchers, nationally and internationally, by establishing the ELPEN Experimental and Research Center which focuses on scientific research and innovation in the pharmaceutical field.

14 November 2013

"Stop experimenting with drug prices", as was stated by Mr. Theodore Tryfon

A profound appeal to stop experimenting with drug prices was made by the Vice President of the Panhellenic Association of Pharmaceutical Industries (PEF) Mr. Theodore Tryfon, to the leadership of the Greek Ministry of Health on Wednesday, November 13, at a Stat Bank event entitled "Health-Drugs-Beauty 2013".

11 November 2013

"Greek pharmaceutical companies adhere strictly to international standards", states Professor Machairas

The fact that the Greek Pharmaceutical Industry meets high production standards was highlighted by Professor Panagiotis Machairas, Biopharmaceutics & Pharmacokinetics, National & Kapodistrian University of Athens, in his speech at the 1st Greek National Conference on "Crisis Management in Healthcare".

09 November 2013

Pharmaceutical expenditure cutbacks pose a great health risk to patients, as stated by leading representatives of the Greek Pharmaceutical sector

An appeal to increase pharmaceutical expenditure in order to ensure the patients's access to reliable and qualitative treatments was made by the leaders of the Pharma sector on Saturday, November 9, at the 1st Greek National Conference on "Crisis Management in the Pharmaceutical Sector".

31 October 2013

ELPEN's strategic global expansion spearheaded by the ground-breaking device: Elpenhaler^{^®}

ELPEN drugs are exported to 60 countries worldwide, 27 of which are in Europe, with the primary aim to achieve further global expansion, spearheaded by Elpenhaler®, an original product, patented by the company's founder, Mr. Dimitrios Pentafragas.